Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 5
Submit an article Journal homepage
233
Views
11
CrossRef citations to date
0
Altmetric
Letters to the Editor

Reactivation of hepatitis B virus following bendamustine-containing chemotherapy in a patient with multiple myeloma

Umit TapanDepartment of Hematology and Oncology, Caritas Carney Hospital, Tufts University School of Medicine, Boston, MA, USACorrespondence[email protected]
,
Sarah K. MayDepartment of Hematology and Oncology, Caritas Carney Hospital, Tufts University School of Medicine, Boston, MA, USA
,
Joseph FioreDepartment of Gastroenterology and Hepatology, Caritas Carney Hospital, Tufts University School of Medicine, Boston, MA, USA
&
Olga KozyrevaDepartment of Internal Medicine, Division of Hematology and Oncology, Saint Elizabeth Medical Center, Tufts University School of Medicine, Boston, MA, USA
Pages 916-918 | Received 20 Nov 2010, Accepted 23 Dec 2010, Published online: 10 Feb 2011

References

  • Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991;100:182–188.
  • Coiffier B. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of lamivudine prophylaxis. Cancer Invest 2006;24:548–552.
  • Tsutsumi Y, Kanamori H, Mori A, et al. Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Saf 2005;4:599–608.
  • Yeo W, Chan TC, Leung NW, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009;27:605–611.
  • Beysel S, Yegin ZA, Yagci M. Bortezomib-associated late hepatitis B reactivation in a case of multiple myeloma. Turk J Gastroenterol 2010;21:197–198.
  • Perceau G, Diris N, Estines O, Derancourt C, Lévy S, Bernard P. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol 2006;155:1053–1056.
  • Picardi M, Pane F, Quintarelli C, et al. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. Haematologica 2003;88:1296–1303.
  • Dennie TW, Kolesar JM. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma. Clin Ther 2009;31: 2290–2311.
  • Kath R, Blumenstengel K, Fricke HJ, Höffken K. Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia. J Cancer Res Clin Oncol 2001;127:48–54.
  • Klippstein A, Schneider CP, Sayer HG, Höffken K. Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer. J Cancer Res Clin Oncol 2003;129:316–319.
  • American Association for the Study of Liver Diseases practice guidelines: chronic hepatitis B: update 2009 [Internet]. [Cited 28 October 2010]. Available from: http://www.aasld.org/practiceguidelines/.
  • Centers for Disease Control and Prevention: recommendations for identification and public health management of persons with chronic hepatitis B virus infection [Internet]. [Cited 28 October 2010]. Available from: http://www.cdc.gov/
  • Artz AS, Somerfield MR, Feld J, et al. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J Clin Oncol 2010;28:3199–3202.
  • Recruiting, completed and active but not recruiting clinical trials with bendamustine [Internet]Bethesda, MAClinicalTrials.gov registry [cited 28 October 2010]. Available from: http://clinicaltrials.gov/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.